A report released by the Global Coalition of TB Activists (GCTA).

The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) is the largest source of funding for the HIV response globally. It is critical that these funds meet the needs of all people living with and affected by HIV.

NEW YORK, NY (20 January 2022) — Today, TB Alliance announced that it has received funding from the United States Agency for International Development (USAID) to jumpstart the search for new tuberculosis (TB) treatments, optimize current treatments so that they can treat children as well as adults, and strengthen health systems in high-TB-burden countries so that all people with TB disease can get treated and quickly return to full health. The funding of up to US$30 million will be administered over a period of 5 years.

Considering the urgent need for prevention of TB among people living with HIV (PLHIV) and to end TB-related deaths, ARK Foundation along with Dimapur Network of Positive People organized a treatment literacy workshop on TB preventive therapy in Dimapur, Nagaland on 20 January 2022.

19 January 2022 | Geneva: The Global Laboratory Initiative (GLI), with its secretariat at the World Health Organization (WHO) Global TB Programme, is pleased to release a Planning and Budgeting Tool for TB and Drug-Resistant TB Testing for calculation of quantities and costs of diagnostic products and laboratory supplies. The tool references product numbers and prices in the Stop TB Partnership Global Drug Facility (GDF) Diagnostics, Medical Devices, and other Health Products Catalog.

A multicomponent diagnostic strategy was found to increase the number of patients being tested, diagnosed, and treated for confirmed tuberculosis (TB) infection, according to results of a cluster-randomized study published in The New England Journal of Medicine.

Revised COVID treatment guidelines: The health ministry has added active TB as a high-risk factor that can potentially cause severe disease and even mortality in COVID-19 patients.

Invest to End TB. Save Lives.
World leaders have only limited time until December 2022 to keep the promises made to their citizens and nations at the 2018 UN High-Level Meeting on TB.

In response to the increase in rates of COVID-19 infection and the rapid spread of the Omicron variant, and recognizing the challenges and uncertainties around changing travel restrictions and local and regional mandates, the 6th Global Forum on TB Vaccines will be convened as a fully virtual event. To facilitate participation, it will now take place over four days, from 22-25 February 2022. Read the full COVID-19 statement here.

RESIST-TB will host a webinar on the latest developments in pediatric pharmacokinetics (PK) of bedaquiline, linezolid, delamanid and pretomanid on 26 January 2022.